Cresco Labs (CRLBF) Consolidated Net Income (2020 - 2026)
Cresco Labs (CRLBF) posted Consolidated Net Income of $11.4 million for Q1 2026, up 113.39% on a QoQ basis from -$85.3 million in Q4 2025, and down 14.72% year-over-year from $13.4 million in Q1 2025.
Cresco Labs (CRLBF) Consolidated Net Income (2020 - 2026) Analysis & Trends
Cresco Labs' Consolidated Net Income history runs 7 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- Quarterly Consolidated Net Income fell 14.72% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.8 million (down 400.19% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
- Consolidated Net Income was $11.4 million for Q1 2026 at Cresco Labs, up from -$85.3 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $39.0 million in Q2 2022 and bottomed at -$156.9 million in Q4 2022.
- A 5-year average of -$12.2 million and a median of $11.3 million in 2024 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2024 — Consolidated Net Income soared 484.76% — and 2025, when it sank 1604.87%.
- Cresco Labs' Consolidated Net Income stood at -$156.9 million in 2022, then surged by 108.17% to $12.8 million in 2023, then tumbled by 55.76% to $5.7 million in 2024, then sank by 1604.87% to -$85.3 million in 2025, then soared by 113.39% to $11.4 million in 2026.
- Business Quant data shows CRLBF's Consolidated Net Income at $11.4 million in Q1 2026, -$85.3 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 11.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.43 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 19.38 Mn |
| Mar 31, 2025 | 13.40 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 11.32 Mn |
| Jun 30, 2024 | -40.94 Mn |
| Mar 31, 2024 | 33.95 Mn |
| Dec 31, 2023 | 12.82 Mn |
| Sep 30, 2023 | -119.19 Mn |
| Jun 30, 2023 | -15.59 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | -156.86 Mn |
| Sep 30, 2022 | 34.22 Mn |
| Jun 30, 2022 | 38.98 Mn |
| Mar 31, 2022 | 21.94 Mn |
| Dec 31, 2021 | 35.15 Mn |
| Sep 30, 2021 | -219.60 Mn |
| Jun 30, 2021 | 29.58 Mn |